Navigation Links
FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
Date:10/18/2007

e(1).

According to Greg Menke, Medical Decisions Network's CEO, "We've seen technology make sweeping improvements in the quality and cost of healthcare. Our MDN-CGS Computerized Insulin Dosing Software is another major contributor to these improvements because it gives hospital clinicians the power to control hyperglycemia, a huge and growing health and cost burden in this country."

The MDN CGS is a networked application, accessible from any computer on a hospital's network. This means that clinicians can continue a patient's infusion progress even when the patient is moved to a new unit.

"This FDA 510(k) clearance will be important for clinical administrators who are considering the move to this beneficial technology and feel more comfortable with FDA's nod," says Menke. "It's an important step for all of us."

For more information, visit http://www.mdnoutcomes.net.

About Medical Decisions Network

Medical Decisions Network (http://www.mdnoutcomes.net) is an affiliate of Medical Automation Systems, the leader in connectivity solutions for clinical laboratory point-of-care data management, and TEG, Virginia, LLC, an international healthcare research and consulting firm. MDN-CGS is a trademark of Medical Decisions Network.

1. Juneja, Rattan, et al, Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit. Diabetes Technology & Therapeutics. Jun 2007, Vol. 9, No. 3: 232-240.

Contact: Rick Import

Office: (866) 791-6108 x 1017

E-mail: rimport@mdnoutcomes.net


'/>"/>
SOURCE Medical Decisions Network
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Spray on contraceptive clears Phase I trial
2. Baby Acne Clears Up On Its Own
3. SC Clears Deck For Implementation Of Nutrition Scheme
4. Bangkoks Public Health Ministry Clears The Northern Province Of Bird Flu Epidemic
5. Cabinet Clears Purchase Preference Policy for Pharma PSUs
6. European Commission Clears Diabetic Insulin for Pregnant Women
7. Delhi Government Clears Healthcare Projects Worth Rs.1.13 bn
8. FDA Clears Breast Cancer Specific Molecular Prognostic Test
9. FDA Clears Critical Limb-Saving Vascular Device
10. Japanese Expedition Clears Half Ton of Garbage from Mt. Everest
11. Painkilling Patch As Effective As Intravenous Delivery Systems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Executive Leadership and CEO Announced for BiPar Sciences 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Caldolor 28R 29 28Ibuprofen 29 Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 6465 1Caldolor 28R 29 28Ibuprofen 29 Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 6465 2Caldolor 28R 29 28Ibuprofen 29 Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 6465 3Sarnova Expands Senior Management Team 6463 1Sarnova Expands Senior Management Team 6463 2Proteon Initiates Second Phase 1 2 Clinical Study of PRT 201 in Hemodialysis Patients 6461 1Proteon Initiates Second Phase 1 2 Clinical Study of PRT 201 in Hemodialysis Patients 6461 2